A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid Tumor
Clinical trial NCT04964375 · UNKNOWN
Trial details
- NCT number
- NCT04964375
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2022-10-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.